Transporting therapeutics across the blood-brain barrier

Molecular Medicine Today

Volumn 2, Issue 3, 1996, Pages 106-113

  Abbott, N Joan ^a   Romero, Ignacio A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DRUG CARRIER; GLYCOPROTEIN P; LIPID;

ANIMAL; BLOOD BRAIN BARRIER; BRAIN DISEASE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; HUMAN; METABOLISM; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN DISEASES; CARRIER PROTEINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LIPIDS; P-GLYCOPROTEIN;

EID: 0030099527     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)88720-X     Document Type: Review

References (41)

1. Minn, A. et al. (1991) Drug metabolizing enzymes in the brain and cerebral microvessels, Brain Res. Rev. 16, 65-82
2. Janzer, R.C. and Raff, M.C. (1987) Astrocytes induce blood-brain barrier properties in endothelial cells, Nature 325, 253-257
3. Wolburg, H. et al. (1994) Modulation of tight junction structure in blood-brain barrier endothelial cells, J. Cell Sci. 107, 1347-1357
4. Greig, N.H. (1992) Drug entry into the brain and its pharmacological manipulation, in The Physiology and Pharmacology of the Blood-brain Barrier (Bradbury, M.W.B., ed.), pp. 487-523, Springer-Verlag
5. Seelig, A., Gottschlich, R. and Devant, R.M. (1994) A method to determine the ability of drugs to diffuse through the blood-brain barrier, Proc. Natl Acad. Sci. USA 91, 68-72
6. Abraham, M., Chadha, H.S. and Mitchell, R.C. (1994) Factors that influence the distribution of solutes between blood and brain, J. Pharm. Sci. 83, 1257-1268
7. Greig, N.H. (1989) Drug delivery to the brain by blood-brain barrier: circumvention and drug modification, in Implications of the Blood-brain Barrier and its Manipulation. Vol. 1 (Neuwelt, E.A., ed.), pp. 311-367, Plenum
8. Oldendorf, W.H. (1977) The blood-brain barrier, in The Ocular and Cerebrospinal Fluids (Bito, L.Z., Davson, H. and Fenstermacher, J.D., eds). pp. 177-190, Academic Press
9. Estes, K.S., Brewster, M.E. and Bodor, N. (1994) Evaluation of an estradiol chemical delivery system (CDS) designed to provide enhanced and sustained hormone levels in the brain. Adv. Drug Deliv. Rev. 14, 167-175
10. Lambert, D.M. et al. (1994) Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3-diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor, Pharm. Res. 12, 187-191
11. van Bree, J.B.M.M. et al. (1991) Stereoselective transport of baclofen across the blood-brain barrier in rats as determined by the unit impulse response methodology, Pharm. Res. 8, 259-262
12. Welty, D.F. et al. (1993) Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate, Epilepsy Res. 16, 175-181
13. Takada, Y. et al. (1992) Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier, Cancer Res. 52, 2191-2196
14. Rapoport, S.I. (1992) Drug delivery to the brain: barrier modification and drug modification methodologies, NIDA Res. Monogr. 120, 121-137
15. Begley, D.J. (1992) Peptides and the blood-brain barrier, in The Physiology and Pharmacology of the Blood-brain Barrier (Bradbury, M.W.B.. ed.), pp. 151-203, Springer-Verlag
16. Wong, S.L., van Bell, K. and Sawchuk, R.J. (1993) Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis, J. Pharmacol. Exp. Ther. 264, 899-909
17. Duckworth, A.S. et al. (1990) Zidovudine with probenecid, Lancet 336, 441
18. Dykstra, K.H. et al. (1993) Microdialysis study of zidovudine (AZT) transport in rat brain, J. Pharmacol. Exp. Ther. 267, 1227-1236
19. Gottesman, M.M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem. 62, 385-427
20. Samuels, B.L. et al. (1993) Modulation of vinblastine resistance with cyclosporine: a Phase I study, J. Clin. Pharmacol. Ther. 54, 421-429
21. Watanabe, T. et al. (1995) Comparative study on reversal efficacy of SDZ PSC833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo, Acta Oncol. 34, 235-241
22. Fukuta, M. et al. (1994) Insulin fragments as a carrier for peptide delivery across the blood-brain barrier, Pharm. Res. 11, 1681-1688
23. Granholm, A.C. et al. (1994) NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants, J. Pharmacol. Exp. Ther. 268, 448-459
24. Bickel, U. et al. (1993) Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery, Proc. Natl Acad. Sci. USA 90, 2618-2622
25. Shin, S-U. et al. (1995) Transferrin-antibody fusion proteins are effective in brain targeting, Proc. Natl Acad. Sci. USA 92, 2820-2824
26. Kang, Y-S. and Pardridge, W.M. (1994) Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin, Pharm. Res. 11, 1257-1264
27. Boado, R. and Pardridge, W.M. (1994) Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide-avidin conjugates, Bioconjug. Chem. 5, 406-410
28. Greenwood, J. (1992) Experimental manipulation of the blood-brain and blood-retinal barriers, in The Physiology and Pharmacology of the Blood-brain Barrier (Bradbury, M.W.B., ed.), pp. 459-486, Springer-Verlag
29. Gumerlock, M.K. and Neuwelt, E. A. (1992) Therapeutic opening of the blood-brain barrier in man, in The Physiology and Pharmacology of the Blood-brain Barrier (Bradbury, M.W.B., ed.), pp. 525-542, Springer-Verlag
30. Neuwelt, E.A. et al. (1994) Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption, Pediatr. Neurosurg. 21, 16-22
31. Doran, S.E. et al. (1995) Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption, Neurosurgery 36, 965-970
32. Neuwelt, E.A. et al. (1994) Delivery of virus-sized iron oxide particles to rodent CNS neurons, Neurosurgery 34, 777-784
33. Nomura, T., Inamura, T. and Black, K.L. (1994) Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors, Brain Res. 659, 62-66
34. Black, K.L. et al. (1990) Selective opening of the blood-tumour barrier by intracarotid infusion of leukotriene C4, J. Neurosurg. 72, 912-916
35. Chamberlain, M.C. et al. (1993) Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A Phase I study, Arch. Neurol. 50, 261-264
36. Tamargo, R.J., Langer, R. and Brem, H. (1994) Interstitial drug delivery to the central nervous system using controlled release polymers: chemotherapy for brain tumours, Methods Neurosci. 21, 135-149
37. Lieberman, D.M. et al. (1994) Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion, J. Neurosurg. 82, 1021-1029
38. Kopin, I.J. et al. (1993) Tissue implants in treatment of parkinsonian syndromes in animals and implications for use of tissue implants in humans, Adv. Neurol. 60, 707-714
39. Leigh, K., Elisevich, K. and Rogers, K.A. (1994) Vascularization and microvascular permeability in solid versus cell-suspension embryonic neural grafts, J. Neurosurg. 81, 272-283
40. Raffel, C. et al. (1994) Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumour transduction with the herpes simplex thymidine kinase/ganciclovir system, Hum. Gene Ther. 5, 863-890
41. Lal, B. et al. (1994) Endothelial cell implantation and survival within experimental gliomas, Proc. Natl Acad. Sci. USA 91, 9695-9699